Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRONVELD PLC AGM Information 2021

Dec 31, 2021

7719_egm_2021-12-31_15d954ac-bd45-45ce-8591-68013e1ecbf0.html

AGM Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 1013X

Ironveld PLC

31 December 2021

Ironveld Plc

("Ironveld" or the "Company")

Notice of AGM

Ironveld announces that its Annual General Meeting ('AGM') will be held at 10.00am (GMT) on Thursday 27 January 2022 at the offices of Kuit Steinart Levy LLP, 7th Floor, Blackfriars House, The Parsonage, Manchester M3 2JA.

The Company's Notice of AGM will be dispatched to shareholders later today and will be available on the Company's website at www.ironveld.com.

For further information, please contact:

Ironveld plc

Martin Eales, Chief Executive Officer
c/o Blytheweigh

+44 20 7138 3204
finnCap (Nomad and Broker)

Christopher Raggett / Charlie Beeson
+44 20 7220 0500
Turner Pope (Joint Broker)

Andrew Thacker/James Pope
+44 20 3657 0050
Blytheweigh

Tim Blythe / Megan Ray
+44 20 7138 3204

NOTES TO EDITORS

Ironveld (IRON.LN) is the owner of Mining Rights over approximately 28 kilometres of outcropping Bushveld magnetite with a SAMREC compliant ore resource of some 56 million tons of ore grading 1,12% V2O5, 68,6% Fe2O3 and 14,7% TiO2.

The Definitive Feasibility Study published in April 2014 confirms the project's viability to deliver a Vanadium slag product for which the company has an offtake agreement as well a High Purity Iron product which commands a premium in the market place and Titanium slag containing commercial grades of titanium.

Ironveld is an AIM traded company. For further information on Ironveld please refer to www.ironveld.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAQBLFXFLLXFBE